RH (RS1.DE) Fundamental Analysis & Valuation

FRA:RS1 • US74967X1037

136.18 EUR
-27.22 (-16.66%)
Last: Mar 2, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This RS1.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

RS1 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 59 industry peers in the Specialty Retail industry. RS1 has a medium profitability rating, but doesn't score so well on its financial health evaluation. RS1 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. RS1.DE Profitability Analysis

1.1 Basic Checks

  • RS1 had positive earnings in the past year.
  • In the past year RS1 had a positive cash flow from operations.
  • RS1 had positive earnings in each of the past 5 years.
  • In the past 5 years RS1 always reported a positive cash flow from operatings.
RS1.DE Yearly Net Income VS EBIT VS OCF VS FCFRS1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M 600M 800M

1.2 Ratios

  • With a Return On Assets value of 2.29%, RS1 perfoms like the industry average, outperforming 54.24% of the companies in the same industry.
  • RS1's Return On Equity of 3285.39% is amongst the best of the industry. RS1 outperforms 100.00% of its industry peers.
  • RS1 has a better Return On Invested Capital (6.54%) than 62.71% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RS1 is in line with the industry average of 10.15%.
Industry RankSector Rank
ROA 2.29%
ROE 3285.39%
ROIC 6.54%
ROA(3y)4.87%
ROA(5y)7.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.51%
ROIC(5y)11.35%
RS1.DE Yearly ROA, ROE, ROICRS1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 1K

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.22%, RS1 is in the better half of the industry, outperforming 66.10% of the companies in the same industry.
  • RS1's Profit Margin has declined in the last couple of years.
  • The Operating Margin of RS1 (10.49%) is better than 86.44% of its industry peers.
  • In the last couple of years the Operating Margin of RS1 has declined.
  • RS1 has a Gross Margin of 44.50%. This is in the better half of the industry: RS1 outperforms 67.80% of its industry peers.
  • In the last couple of years the Gross Margin of RS1 has remained more or less at the same level.
Industry RankSector Rank
OM 10.49%
PM (TTM) 3.22%
GM 44.5%
OM growth 3Y-26.37%
OM growth 5Y-6.4%
PM growth 3Y-50.1%
PM growth 5Y-22.84%
GM growth 3Y-3.41%
GM growth 5Y1.47%
RS1.DE Yearly Profit, Operating, Gross MarginsRS1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. RS1.DE Health Analysis

2.1 Basic Checks

  • RS1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, RS1 has more shares outstanding
  • Compared to 5 years ago, RS1 has less shares outstanding
  • Compared to 1 year ago, RS1 has an improved debt to assets ratio.
RS1.DE Yearly Shares OutstandingRS1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
RS1.DE Yearly Total Debt VS Total AssetsRS1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • RS1 has an Altman-Z score of 1.25. This is a bad value and indicates that RS1 is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.25, RS1 is doing worse than 66.10% of the companies in the same industry.
  • RS1 has a debt to FCF ratio of 25.66. This is a negative value and a sign of low solvency as RS1 would need 25.66 years to pay back of all of its debts.
  • RS1 has a Debt to FCF ratio of 25.66. This is in the lower half of the industry: RS1 underperforms 66.10% of its industry peers.
  • A Debt/Equity ratio of 944.39 is on the high side and indicates that RS1 has dependencies on debt financing.
  • The Debt to Equity ratio of RS1 (944.39) is worse than 91.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 944.39
Debt/FCF 25.66
Altman-Z 1.25
ROIC/WACC0.71
WACC9.2%
RS1.DE Yearly LT Debt VS Equity VS FCFRS1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.19 indicates that RS1 should not have too much problems paying its short term obligations.
  • The Current ratio of RS1 (1.19) is comparable to the rest of the industry.
  • RS1 has a Quick Ratio of 1.19. This is a bad value and indicates that RS1 is not financially healthy enough and could expect problems in meeting its short term obligations.
  • RS1's Quick ratio of 0.26 is on the low side compared to the rest of the industry. RS1 is outperformed by 84.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.26
RS1.DE Yearly Current Assets VS Current LiabilitesRS1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RS1.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 41.43% over the past year.
  • The earnings per share for RS1 have been decreasing by -14.46% on average. This is quite bad
  • RS1 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.74%.
  • Measured over the past years, RS1 shows a small growth in Revenue. The Revenue has been growing by 3.74% on average per year.
EPS 1Y (TTM)41.43%
EPS 3Y-41.01%
EPS 5Y-14.46%
EPS Q2Q%-31.05%
Revenue 1Y (TTM)9.74%
Revenue growth 3Y-5.41%
Revenue growth 5Y3.74%
Sales Q2Q%8.88%

3.2 Future

  • Based on estimates for the next years, RS1 will show a very strong growth in Earnings Per Share. The EPS will grow by 45.55% on average per year.
  • The Revenue is expected to grow by 8.19% on average over the next years. This is quite good.
EPS Next Y36.4%
EPS Next 2Y41.79%
EPS Next 3Y40.1%
EPS Next 5Y45.55%
Revenue Next Year8.46%
Revenue Next 2Y8.69%
Revenue Next 3Y8.43%
Revenue Next 5Y8.19%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RS1.DE Yearly Revenue VS EstimatesRS1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
RS1.DE Yearly EPS VS EstimatesRS1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

5

4. RS1.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • RS1 is valuated rather expensively with a Price/Earnings ratio of 24.90.
  • Based on the Price/Earnings ratio, RS1 is valued a bit cheaper than the industry average as 61.02% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.83. RS1 is around the same levels.
  • RS1 is valuated correctly with a Price/Forward Earnings ratio of 14.69.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of RS1 indicates a somewhat cheap valuation: RS1 is cheaper than 66.10% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.95. RS1 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.9
Fwd PE 14.69
RS1.DE Price Earnings VS Forward Price EarningsRS1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RS1 is on the same level as its industry peers.
  • RS1's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.75
EV/EBITDA 12.26
RS1.DE Per share dataRS1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • RS1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • RS1 has a very decent profitability rating, which may justify a higher PE ratio.
  • RS1's earnings are expected to grow with 40.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.68
PEG (5Y)N/A
EPS Next 2Y41.79%
EPS Next 3Y40.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RS1.DE Dividend Analysis

5.1 Amount

  • RS1 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RS1.DE Fundamentals: All Metrics, Ratios and Statistics

RH

FRA:RS1 (3/2/2026, 7:00:00 PM)

136.18

-27.22 (-16.66%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)12-11
Earnings (Next)06-10
Inst Owners88.19%
Inst Owner ChangeN/A
Ins Owners18.46%
Ins Owner ChangeN/A
Market Cap2.56B
Revenue(TTM)3.41B
Net Income(TTM)109.93M
Analysts70
Price Target214.74 (57.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-17.17%
Min EPS beat(2)-23.18%
Max EPS beat(2)-11.15%
EPS beat(4)1
Avg EPS beat(4)47.13%
Min EPS beat(4)-23.18%
Max EPS beat(4)242.76%
EPS beat(8)2
Avg EPS beat(8)-11.2%
EPS beat(12)4
Avg EPS beat(12)-16.41%
EPS beat(16)7
Avg EPS beat(16)-7.8%
Revenue beat(2)0
Avg Revenue beat(2)-3.2%
Min Revenue beat(2)-3.5%
Max Revenue beat(2)-2.9%
Revenue beat(4)0
Avg Revenue beat(4)-3.68%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)-2.9%
Revenue beat(8)0
Avg Revenue beat(8)-3.8%
Revenue beat(12)0
Avg Revenue beat(12)-3.34%
Revenue beat(16)2
Avg Revenue beat(16)-2.84%
PT rev (1m)0%
PT rev (3m)-30.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.18%
EPS NY rev (1m)-2.41%
EPS NY rev (3m)-60.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.13%
Valuation
Industry RankSector Rank
PE 24.9
Fwd PE 14.69
P/S 0.87
P/FCF 23.75
P/OCF 8.8
P/B 887.09
P/tB N/A
EV/EBITDA 12.26
EPS(TTM)5.47
EY4.02%
EPS(NY)9.27
Fwd EY6.81%
FCF(TTM)5.73
FCFY4.21%
OCF(TTM)15.48
OCFY11.37%
SpS156.42
BVpS0.15
TBVpS-10.1
PEG (NY)0.68
PEG (5Y)N/A
Graham Number4.35
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 3285.39%
ROCE 9.3%
ROIC 6.54%
ROICexc 6.62%
ROICexgc 7.03%
OM 10.49%
PM (TTM) 3.22%
GM 44.5%
FCFM 3.67%
ROA(3y)4.87%
ROA(5y)7.29%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.51%
ROIC(5y)11.35%
ROICexc(3y)10.6%
ROICexc(5y)15.54%
ROICexgc(3y)11.39%
ROICexgc(5y)17.05%
ROCE(3y)12.08%
ROCE(5y)16.12%
ROICexgc growth 3Y-40.85%
ROICexgc growth 5Y-20.42%
ROICexc growth 3Y-40.13%
ROICexc growth 5Y-18.93%
OM growth 3Y-26.37%
OM growth 5Y-6.4%
PM growth 3Y-50.1%
PM growth 5Y-22.84%
GM growth 3Y-3.41%
GM growth 5Y1.47%
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 944.39
Debt/FCF 25.66
Debt/EBITDA 6.32
Cap/Depr 149.24%
Cap/Sales 6.23%
Interest Coverage 250
Cash Conversion 67.48%
Profit Quality 113.67%
Current Ratio 1.19
Quick Ratio 0.26
Altman-Z 1.25
F-Score7
WACC9.2%
ROIC/WACC0.71
Cap/Depr(3y)187.83%
Cap/Depr(5y)173.54%
Cap/Sales(3y)6.99%
Cap/Sales(5y)5.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.43%
EPS 3Y-41.01%
EPS 5Y-14.46%
EPS Q2Q%-31.05%
EPS Next Y36.4%
EPS Next 2Y41.79%
EPS Next 3Y40.1%
EPS Next 5Y45.55%
Revenue 1Y (TTM)9.74%
Revenue growth 3Y-5.41%
Revenue growth 5Y3.74%
Sales Q2Q%8.88%
Revenue Next Year8.46%
Revenue Next 2Y8.69%
Revenue Next 3Y8.43%
Revenue Next 5Y8.19%
EBIT growth 1Y16.26%
EBIT growth 3Y-30.35%
EBIT growth 5Y-2.9%
EBIT Next Year55.61%
EBIT Next 3Y25.79%
EBIT Next 5Y26.15%
FCF growth 1Y-33.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.11%
OCF growth 3Y-70.44%
OCF growth 5Y-44.98%

RH / RS1.DE FAQ

What is the ChartMill fundamental rating of RH (RS1.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to RS1.DE.


What is the valuation status for RS1 stock?

ChartMill assigns a valuation rating of 5 / 10 to RH (RS1.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for RH?

RH (RS1.DE) has a profitability rating of 6 / 10.


Can you provide the financial health for RS1 stock?

The financial health rating of RH (RS1.DE) is 2 / 10.


What is the expected EPS growth for RH (RS1.DE) stock?

The Earnings per Share (EPS) of RH (RS1.DE) is expected to grow by 36.4% in the next year.